7,045 CVS Health Corporation $CVS Shares Purchased by Cullinan Associates Inc.

Cullinan Associates Inc. lifted its stake in CVS Health Corporation (NYSE:CVS) by 15.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,469 shares of the pharmacy operator’s stock after acquiring an additional 7,045 shares during the quarter. Cullinan Associates Inc.’s holdings in CVS Health were worth $4,582,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. Ethic Inc. boosted its stake in shares of CVS Health by 6.7% in the 3rd quarter. Ethic Inc. now owns 48,352 shares of the pharmacy operator’s stock worth $4,143,000 after buying an additional 3,018 shares during the last quarter. StoneX Group Inc. increased its position in CVS Health by 8.9% during the third quarter. StoneX Group Inc. now owns 27,707 shares of the pharmacy operator’s stock valued at $2,374,000 after acquiring an additional 2,255 shares during the last quarter. Pictet Asset Management Holding SA lifted its holdings in CVS Health by 31.3% in the third quarter. Pictet Asset Management Holding SA now owns 1,072,981 shares of the pharmacy operator’s stock valued at $91,951,000 after acquiring an additional 255,680 shares during the period. Formidable Asset Management LLC lifted its holdings in CVS Health by 21.1% in the third quarter. Formidable Asset Management LLC now owns 12,109 shares of the pharmacy operator’s stock valued at $1,038,000 after acquiring an additional 2,106 shares during the period. Finally, Parallel Advisors LLC boosted its position in CVS Health by 1.4% in the third quarter. Parallel Advisors LLC now owns 14,139 shares of the pharmacy operator’s stock worth $1,212,000 after purchasing an additional 200 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CVS shares. Argus boosted their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, August 19th. Piper Sandler set a $112.00 price objective on shares of CVS Health in a report on Wednesday, September 9th. Evercore restated an “outperform” rating on shares of CVS Health in a research report on Wednesday. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Finally, TD Cowen reiterated a “buy” rating on shares of CVS Health in a research report on Wednesday. Twenty-two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $108.25.

CVS Health Stock Performance

NYSE:CVS opened at $83.76 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. The stock has a 50-day simple moving average of $90.37 and a two-hundred day simple moving average of $88.89. The firm has a market capitalization of $107.17 billion, a PE ratio of 9.75, a P/E/G ratio of 0.76 and a beta of 0.58. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same quarter last year, the company earned $1.60 earnings per share. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. Analysts forecast that CVS Health Corporation will post 8.25 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were issued a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 30.97%.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

Insider Buying and Selling

In other news, EVP Prem Shah bought 23,855 shares of the firm’s stock in a transaction on Friday, November 6th. The shares were bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the purchase, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.